N@N

OCLS, GBF, NEPT, AAV, KTCC, NBY Are Seasonally Ripe To Go Down In the Next Five Weeks

November 30, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Oculus Innovative Sciences Inc (NASDAQ:OCLS), iShares Barclays Government/Credit Bond Fund (NYSE:GBF), Neptun SA (NASDAQ:NEPT), Advantage Oil & Gas Ltd (NYSE:AAV), Key Tronic Corp (NASDAQ:KTCC), Novabay Pharmaceuticals Inc (AMEX:NBY) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  OCLS    Oculus Innovative Sciences Inc   -4.92%           100.00% (5 of 5)     Thursday, December 6th 2012
  GBF     iShares Barclays Government/Credit Bond Fund  -0.71%           100.00% (5 of 5)     Friday, December 7th 2012
  NEPT    Neptun SA                        -7.44%           100.00% (5 of 5)     Monday, December 17th 2012
  AAV     Advantage Oil & Gas Ltd          -3.60%           66.67% (4 of 6)      Wednesday, December 5th 2012
  KTCC    Key Tronic Corp                  -5.31%           75.00% (9 of 12)     Friday, December 14th 2012
  NBY     Novabay Pharmaceuticals Inc      -3.23%           100.00% (5 of 5)     Friday, December 14th 2012

Oculus Innovative Sciences Inc (NASDAQ:OCLS) - Oculus Innovative Sciences, Inc. develops, manufactures, and markets tissue care products based on Microcyn platform technology to treat infections and enhance healing while reducing the need for antibiotics. Its Microcyn platform technology, a solution of electrically charged oxychlorine small molecules, treats various organisms that cause disease or pathogens, including viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in wounds, as well as Clostridium difficile. The company offers Microcyn-based products primarily through its Website, and various regional distributors principally in the United States, Europe, and Mexico. It sells its products to hospitals, physicians, and nurses; and other healthcare practitioners, who are the caregivers to patients being treated for acute or chronic wounds, as well as those patients undergoing surgical procedures. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences was incorporated in 1999 and is based in Petaluma, California..

iShares Barclays Government/Credit Bond Fund (NYSE:GBF) - iShares Trust iShares Lehman Government/Credit Bond Fund.

Neptun SA (NASDAQ:NEPT) - Neptune Technologies & Bioressources Inc., a biotechnology company, engages in the research, development, and commercialization of products derived from marine biomasses for the nutraceutical, pharmaceutical, and cosmetic industries. It offers Neptune Krill Oil (NKO), a marine oil that provides a blend of nutritional elements; Neptune Krill Aquatein, a protein concentrate that contains amino acids; and OPA3 for the functional food and biopharmaceutical markets. The companys NKO product prevents skin damages caused by chronic exposure to UV radiation; reduces the physical and emotional symptoms associated with premenstrual syndrome; provides relief from dysmenorrheal; and controls hyperlipidemia by reducing the cholesterol levels. It sells its products in Canada, the United States, Europe, and Asia/Oceania. The company was founded in 1925 and is headquartered in Laval, Canada..

Advantage Oil & Gas Ltd (NYSE:AAV) - Advantage Oil & Gas Ltd. engages in the business of oil and gas exploitation, development, acquisition, and production in the provinces of Alberta and Saskatchewan, Canada. The companys principal properties include the Glacier property, the Westerose property, the Lookout Butte property, the Brazeau-Ferrier area, the Sunset/Valleyview area, and the Nevis property located in Alberta; three shallow gas properties located at Medicine Hat, Bantry, and Shouldice; a host of individual properties within the Williston Sedimentary Basin in the southeast corner of Saskatchewan; and the Wapella property. It also has interests in heavy oil properties, including the Lashburn, West Hazel, and Eyehill properties located in the heart of the Lloydminster heavy oil producing area. As of December 31, 2009, Advantage Oil & Gas proved plus probable reserves were 232.3 million barrels of oil equivalent. The company was founded in 2001 and is headquartered in Calgary, Canada..

Key Tronic Corp (NASDAQ:KTCC) - Key Tronic Corporation, doing business as KeyTronicEMS Co., together with its subsidiaries, provides electronic manufacturing services (EMS) to original equipment manufacturers primarily in the United States, Mexico, and China. Its EMS services include product design, surface mount technologies for printed circuit board assembly, tool making, precision plastic molding, liquid injection molding, automated tape winding, prototype design, and full product builds. The company also manufactures keyboards and other input devices for personal computers. Key Tronic markets its products and services primarily through its direct sales department aided by field sales people and distributors. The company was founded in 1968 and is headquartered in Spokane Valley, Washington..

Novabay Pharmaceuticals Inc (AMEX:NBY) - NovaBay Pharmaceuticals Inc., a clinical stage biotechnology company, engages in developing proprietary and patented topical Aganocide compounds for the treatment and prevention of various infections without causing bacterial resistance. Its Aganocide compounds are synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells. The company is developing commercial opportunities for its portfolio of anti-infective Aganocide compounds in four healthcare markets, including dermatology, ophthalmology, urology, and hospital infections. Its lead product candidate, NVC-422, is used for the treatment of adenoviral conjunctivitis, a type of Pink Eye; killing of P. acne, the bacterium associated with inflamed acne lesions, and other known dermal pathogens; and treatment of uropathogens, including Proteus mirabilis, a gram-negative bacterium that can cause urinary catheter blockage and encrustation. The company is also developing NVC-101, an acidic composition of hypochlorous acid to promote wound healing, tissue repair, and tissue regeneration. NovaBay Pharmaceuticals has a licensing and research collaboration agreement with Alcon Manufacturing Ltd. for use of its Aganocide compounds in the eye, ear, and sinus infections, as well as for contact lens solutions; and with Galderma S.A. to develop and commercialize its Aganocide compounds in acne, impetigo, and other dermatological indications. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals was incorporated in 2000 and is based in Emeryville, California..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641